Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?
The renin-angiotensin system (RAS) is an important cascade of enzymes and peptides that regulates blood pressure, volume, and electrolytes. Within this complex system of reactions, its counter-regulatory axis has attracted attention, which has been associated with the pathophysiology of inflammatory...
Saved in:
Main Authors: | Diana V. Ávila-Martínez (Author), Wendy K. Mixtega-Ruiz (Author), José M. Hurtado-Capetillo (Author), Oscar Lopez-Franco (Author), Mónica Flores-Muñoz (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
by: Javier Egea, et al.
Published: (2022) -
Regulation of Ras Signaling by S-Nitrosylation
by: Sónia Simão, et al.
Published: (2023) -
A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease
by: Ignacio Prieto, et al.
Published: (2023) -
Inflammatory and Fibrotic Mediators in Renal Diseases
by: Sandra Rayego-Mateos, et al.
Published: (2019) -
Rãs
by: Maria de Fátima Sousa e Silva
Published: (2014)